background image

Paid Clinical Trials Bangor

Discover 72 paid clinical trials in Bangor, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: Brewer ME, Augusta ME, Methuen MA, Boston MA,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 65+

Code: NCT06377852

Phase3, Recruiting
New

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Bangor ME, Scarborough ME, Lebanon NH, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 365 - 30

Code: NCT03126916

Phase3, Recruiting

Micronutrients as Adjunctive Treatment for Bipolar Disorder

for
Bipolar Disorder
Location: Bangor ME
Sponsor: Eastern Maine Medical Center

Sex: All

Age: 18+

Code: NCT03541031

Recruiting

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

for
Ganglioneuroblastoma, Localized Resectable Neuroblastoma,
Location: Bangor ME, Scarborough ME, Quebec, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT00904241

Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Bangor ME, Boston MA, Hartford CT, Albany NY,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Bangor ME, Scarborough ME, Sherbrooke, Quebec,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

for
Alzheimer's Disease
Location: Bangor ME, Sherbrooke, Victoriaville, Levis, Quebec,
Sponsor: Eli Lilly and Company

Sex: All

Age: 55 - 70+

Code: NCT06653153

Phase3, Recruiting

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

for
Asthma
Location: Bangor ME, Quebec, Dover MA, Hawthorne NY, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06572228

Recruiting

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

for
Recurrent B Acute Lymphoblastic Leukemia,
Location: Bangor ME, Scarborough ME, Lebanon NH, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT02981628

Phase2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Bangor ME, Sherbrooke, Levis, Quebec, Granby,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting